Lupin is rolling out tolvaptan tablets, 15 mg, 30 mg, 45 mg, 60 mg and 90 mg in the United States. Lupin holds the exclusive first-to-file status for this product and will have 180-day generic drug ...

Sandoz Inc. was hit with a patent infringement lawsuit on March 5 in Delaware District Court over its attempt to market a generic version of Jynarque, a kidney disease medication. The action, brought ...

Tolvaptan dosing was started in daily morning and afternoon doses of 45 mg and 15 mg, respectively, with weekly increases to 60 mg and 30 mg and then to 90 mg and 30 mg, according to patient-reported ...